Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging

Fabian Dorninger, Ann B. Moser, Jianqiu Kou, Christoph Wiesinger, Sonja Forss-Petter, Andreas Gleiss, Margareta Hinterberger, Susanne Jungwirth, Peter Fischer, Johannes Berger

Research output: Contribution to journalArticle

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disease and of continuously rising prevalence. The identification of easy-to-measure biomarkers capable to assist in the prediction and early diagnosis of AD is currently a main research goal. Lipid metabolites in peripheral blood of human patients have recently gained major attention in this respect. Here, we analyzed plasma of 174 participants (not demented at baseline; mean age: 75.70±0.44 years) of the Vienna Transdanube Aging (VITA) study, a longitudinal, population-based birth cohort study, at baseline and after 90 months or at diagnosis of probable AD. We determined the levels of specific choline phospholipids, some of which have been suggested as potential biomarkers for the prediction of AD. Our results show that during normal aging the levels of lysophosphatidylcholine, choline plasmalogen, and lyso-platelet activating factor increase significantly. Notably, we observed similar but more pronounced changes in the group that developed probable AD. Thus, our results imply that, in terms of choline-containing plasma phospholipids, the conversion to AD mimics an accelerated aging process. We conclude that age, even in the comparatively short time frame between 75 and 82.5 years, is a crucial factor in the quest for plasma lipid biomarkers for AD that must be carefully considered in future studies and trials.

Original languageEnglish (US)
Pages (from-to)841-854
Number of pages14
JournalJournal of Alzheimer's Disease
Volume62
Issue number2
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

Fingerprint

Choline
Phospholipids
Alzheimer Disease
Biomarkers
Lipids
Lysophosphatidylcholines
tebufenozide
Neurodegenerative Diseases
Longitudinal Studies
Early Diagnosis
Cohort Studies
Parturition
Research
Population

Keywords

  • Biomarkers
  • blood
  • lyso-PAF
  • lysophosphatidylcholines
  • lysophospholipids
  • mass spectrometry
  • plasmalogens

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging. / Dorninger, Fabian; Moser, Ann B.; Kou, Jianqiu; Wiesinger, Christoph; Forss-Petter, Sonja; Gleiss, Andreas; Hinterberger, Margareta; Jungwirth, Susanne; Fischer, Peter; Berger, Johannes.

In: Journal of Alzheimer's Disease, Vol. 62, No. 2, 01.01.2018, p. 841-854.

Research output: Contribution to journalArticle

Dorninger, F, Moser, AB, Kou, J, Wiesinger, C, Forss-Petter, S, Gleiss, A, Hinterberger, M, Jungwirth, S, Fischer, P & Berger, J 2018, 'Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging', Journal of Alzheimer's Disease, vol. 62, no. 2, pp. 841-854. https://doi.org/10.3233/JAD-171036
Dorninger, Fabian ; Moser, Ann B. ; Kou, Jianqiu ; Wiesinger, Christoph ; Forss-Petter, Sonja ; Gleiss, Andreas ; Hinterberger, Margareta ; Jungwirth, Susanne ; Fischer, Peter ; Berger, Johannes. / Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging. In: Journal of Alzheimer's Disease. 2018 ; Vol. 62, No. 2. pp. 841-854.
@article{bb20583651534bff94056881987cd0b7,
title = "Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging",
abstract = "Alzheimer's disease (AD) is the most common neurodegenerative disease and of continuously rising prevalence. The identification of easy-to-measure biomarkers capable to assist in the prediction and early diagnosis of AD is currently a main research goal. Lipid metabolites in peripheral blood of human patients have recently gained major attention in this respect. Here, we analyzed plasma of 174 participants (not demented at baseline; mean age: 75.70±0.44 years) of the Vienna Transdanube Aging (VITA) study, a longitudinal, population-based birth cohort study, at baseline and after 90 months or at diagnosis of probable AD. We determined the levels of specific choline phospholipids, some of which have been suggested as potential biomarkers for the prediction of AD. Our results show that during normal aging the levels of lysophosphatidylcholine, choline plasmalogen, and lyso-platelet activating factor increase significantly. Notably, we observed similar but more pronounced changes in the group that developed probable AD. Thus, our results imply that, in terms of choline-containing plasma phospholipids, the conversion to AD mimics an accelerated aging process. We conclude that age, even in the comparatively short time frame between 75 and 82.5 years, is a crucial factor in the quest for plasma lipid biomarkers for AD that must be carefully considered in future studies and trials.",
keywords = "Biomarkers, blood, lyso-PAF, lysophosphatidylcholines, lysophospholipids, mass spectrometry, plasmalogens",
author = "Fabian Dorninger and Moser, {Ann B.} and Jianqiu Kou and Christoph Wiesinger and Sonja Forss-Petter and Andreas Gleiss and Margareta Hinterberger and Susanne Jungwirth and Peter Fischer and Johannes Berger",
year = "2018",
month = "1",
day = "1",
doi = "10.3233/JAD-171036",
language = "English (US)",
volume = "62",
pages = "841--854",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging

AU - Dorninger, Fabian

AU - Moser, Ann B.

AU - Kou, Jianqiu

AU - Wiesinger, Christoph

AU - Forss-Petter, Sonja

AU - Gleiss, Andreas

AU - Hinterberger, Margareta

AU - Jungwirth, Susanne

AU - Fischer, Peter

AU - Berger, Johannes

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Alzheimer's disease (AD) is the most common neurodegenerative disease and of continuously rising prevalence. The identification of easy-to-measure biomarkers capable to assist in the prediction and early diagnosis of AD is currently a main research goal. Lipid metabolites in peripheral blood of human patients have recently gained major attention in this respect. Here, we analyzed plasma of 174 participants (not demented at baseline; mean age: 75.70±0.44 years) of the Vienna Transdanube Aging (VITA) study, a longitudinal, population-based birth cohort study, at baseline and after 90 months or at diagnosis of probable AD. We determined the levels of specific choline phospholipids, some of which have been suggested as potential biomarkers for the prediction of AD. Our results show that during normal aging the levels of lysophosphatidylcholine, choline plasmalogen, and lyso-platelet activating factor increase significantly. Notably, we observed similar but more pronounced changes in the group that developed probable AD. Thus, our results imply that, in terms of choline-containing plasma phospholipids, the conversion to AD mimics an accelerated aging process. We conclude that age, even in the comparatively short time frame between 75 and 82.5 years, is a crucial factor in the quest for plasma lipid biomarkers for AD that must be carefully considered in future studies and trials.

AB - Alzheimer's disease (AD) is the most common neurodegenerative disease and of continuously rising prevalence. The identification of easy-to-measure biomarkers capable to assist in the prediction and early diagnosis of AD is currently a main research goal. Lipid metabolites in peripheral blood of human patients have recently gained major attention in this respect. Here, we analyzed plasma of 174 participants (not demented at baseline; mean age: 75.70±0.44 years) of the Vienna Transdanube Aging (VITA) study, a longitudinal, population-based birth cohort study, at baseline and after 90 months or at diagnosis of probable AD. We determined the levels of specific choline phospholipids, some of which have been suggested as potential biomarkers for the prediction of AD. Our results show that during normal aging the levels of lysophosphatidylcholine, choline plasmalogen, and lyso-platelet activating factor increase significantly. Notably, we observed similar but more pronounced changes in the group that developed probable AD. Thus, our results imply that, in terms of choline-containing plasma phospholipids, the conversion to AD mimics an accelerated aging process. We conclude that age, even in the comparatively short time frame between 75 and 82.5 years, is a crucial factor in the quest for plasma lipid biomarkers for AD that must be carefully considered in future studies and trials.

KW - Biomarkers

KW - blood

KW - lyso-PAF

KW - lysophosphatidylcholines

KW - lysophospholipids

KW - mass spectrometry

KW - plasmalogens

UR - http://www.scopus.com/inward/record.url?scp=85043598936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043598936&partnerID=8YFLogxK

U2 - 10.3233/JAD-171036

DO - 10.3233/JAD-171036

M3 - Article

C2 - 29480199

AN - SCOPUS:85043598936

VL - 62

SP - 841

EP - 854

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -